Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Cardiology · Chronic Chagasic Cardiomyopathy

What Is an Apical Aneurysm in Chagas Disease?

At a Glance

An apical aneurysm is a bulging, scarred area at the bottom of the heart caused by chronic Chagas disease. While it rarely bursts, it can lead to serious complications like blood clots, strokes, and abnormal heart rhythms, which require careful management with medications and monitoring.

In this answer

3 sections

01

Why Does Chagas Disease Cause Apical Aneurysms?

02

Clinical Significance and Associated Risks

03

How It Is Managed

An apical aneurysm is a structural change characterized by a thinning and bulging of the heart muscle, typically occurring at the very bottom tip (the apex) of the left ventricle. In the context of chronic Chagasic cardiomyopathy (American trypanosomiasis), this change is a hallmark sign that the heart has been affected by a persistent, long-term infection with the Trypanosoma cruzi parasite [1][2].

If your cardiologist mentioned you have an apical aneurysm, it means a specific section of your heart muscle has become scarred and weakened over time, causing it to balloon outward rather than contracting normally during a heartbeat [3][4].

Importantly, when people hear the word “aneurysm,” they often think of a brain or aortic aneurysm that might suddenly burst or rupture. However, an apical aneurysm in the heart is very different. Because it is formed from thick, tough scar tissue, the risk of it actually “bursting” is extremely low. The aneurysm itself is usually painless and “silent,” often discovered only during a routine ultrasound of the heart [3].

Why Does Chagas Disease Cause Apical Aneurysms?

Chronic Chagas disease triggers ongoing inflammation within the heart tissue [1][5]. Over many years, this relentless immune response destroys healthy muscle cells, replacing them with thick, stiff scar tissue—a process known as fibrosis [3][4].

Because the bottom tip of the heart is particularly vulnerable to this damage and to reduced blood flow, the scarred tissue eventually becomes too thin to handle the normal pressure of the heart pumping [3][6]. As a result, the weakened area stretches and bulges outward.

Clinical Significance and Associated Risks

While an apical aneurysm rarely ruptures, it significantly impacts how your heart functions. The loss of normal pumping action at the tip of the heart can contribute to heart failure, where the heart’s overall ability to pump blood (its ejection fraction) drops, which may cause you to feel fatigued or short of breath [7][8]. The two other most important risks require careful medical management: blood clots and arrhythmias.

Risk of Blood Clots and Stroke

When the tip of the heart balloons outward and stops squeezing properly, blood can pool or stagnate in that area [9][10]. This stagnant blood is prone to clotting, forming what doctors call a mural thrombus inside the heart.

If a piece of this blood clot breaks loose, it can travel through the bloodstream to the brain, causing a stroke, or to other parts of the body [11][9]. Because of this risk, your doctor may prescribe blood thinners (anticoagulation therapy) to prevent clots from forming and significantly reduce the risk of a stroke [12][13].

Heart Rhythm Issues (Arrhythmias)

The extensive scar tissue that forms the aneurysm disrupts the heart’s normal electrical pathways [14][15]. This scarred area acts as a focal point for chaotic electrical signals, making the heart vulnerable to rapid, abnormal heartbeats called ventricular arrhythmias [15][16]. These abnormal rhythms can cause palpitations, fainting spells, and in severe cases, life-threatening sudden cardiac events [14][15].

How It Is Managed

If you have been diagnosed with an apical aneurysm, your cardiology team will monitor you closely. An echocardiogram (heart ultrasound) or a Cardiac MRI can show the size of the aneurysm, check for blood clots, and evaluate your heart’s overall pumping strength [17][18].

While the aneurysm itself cannot be reversed, its complications are very treatable. With proper medical care, many patients live long, stable lives. Your care team will focus on preventing complications through medications (like blood thinners or heart failure treatments) and monitoring your heart rhythm. If your risk for dangerous arrhythmias is high, they may discuss placing an implantable cardioverter-defibrillator (ICD) to keep your heart rhythm safe [14][16].

Common questions in this guide

Can an apical aneurysm in the heart burst?
Unlike brain or aortic aneurysms, an apical aneurysm in the heart is very unlikely to burst. It is formed from thick, tough scar tissue rather than a fragile blood vessel wall. However, it still requires careful medical monitoring to manage other heart-related risks.
Why do I need to take blood thinners for an apical aneurysm?
When the tip of the heart balloons outward, blood can pool and become stagnant in that area, increasing the risk of a blood clot. If a clot breaks loose, it can travel to the brain and cause a stroke. Blood thinners help prevent these dangerous clots from forming.
How does an apical aneurysm affect my heart rhythm?
The thick scar tissue that forms the aneurysm can disrupt your heart's normal electrical pathways. This can trigger chaotic electrical signals, leading to rapid, abnormal heartbeats called ventricular arrhythmias. Your doctor may monitor you for symptoms like palpitations or fainting.
Can an apical aneurysm be cured or reversed?
An apical aneurysm cannot be reversed because it is made of permanent scar tissue. However, the complications associated with it are highly treatable. With proper medications and routine heart monitoring, many people with this condition live long and stable lives.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How large is my apical aneurysm, and how often will we monitor it with an echocardiogram?
  2. 2.Do my current imaging results show any signs of a blood clot (thrombus) inside the aneurysm?
  3. 3.Based on my aneurysm and overall heart function, should I be taking blood thinners to prevent a stroke?
  4. 4.What specific symptoms—such as certain types of palpitations or fainting—should prompt me to contact you or go to the emergency room?
  5. 5.How does this aneurysm affect my ejection fraction and overall risk for heart failure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Chagas Disease: Is There an Age Limit for Benznidazole?Do Benznidazole & Nifurtimox Reverse Chagas Heart Damage?Can I Donate Blood After Chagas Treatment?Can I Prevent Passing Chagas Disease to My Baby?Did My Chagas Treatment Work If Antibodies Are Positive?How Do Immunosuppressants Affect Chagas Disease?How Often Should You Get an ECG for Silent Chagas?Is Chagas Disease Contagious From Person to Person?Options if You Stop Benznidazole for Side EffectsWhat Are the Digestive Symptoms of Chagas Disease?What Causes a False-Positive Chagas Disease Blood Test?What is Romaña's Sign in Acute Chagas Disease?What is the Kuschnir Classification for Chagas Disease?Life Expectancy with Silent Phase Chagas DiseaseWhat Is the Risk of Getting Chagas from a Kissing Bug Bite?What Specialists Treat Chagas Disease? | Inciteful MedWhich Family Members Need Chagas Disease Screening?Why Must You Avoid Alcohol During Chagas Treatment?Why Is Chagas Disease Frequently Missed in the US?

References

References (18)
  1. 1

    Pathology and Pathogenesis of Chagas Heart Disease.

    Bonney KM, Luthringer DJ, Kim SA, et al.

    Annual review of pathology 2019; (14()):421-447 doi:10.1146/annurev-pathol-020117-043711.

    PMID: 30355152
  2. 2

    Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death.

    Pino-Marín A, Medina-Rincón GJ, Gallo-Bernal S, et al.

    Pathogens (Basel, Switzerland) 2021; (10(5)) doi:10.3390/pathogens10050505.

    PMID: 33922366
  3. 3

    Endogenous osteopontin induces myocardial CCL5 and MMP-2 activation that contributes to inflammation and cardiac remodeling in a mouse model of chronic Chagas heart disease.

    Caballero EP, Santamaría MH, Corral RS

    Biochimica et biophysica acta. Molecular basis of disease 2018; (1864(1)):11-23 doi:10.1016/j.bbadis.2017.10.006.

    PMID: 28987763
  4. 4

    Ventricular Tachycardia in the Setting of Chagasic Cardiomyopathy: Use of Voltage Mapping to Characterize Endoepicardial Nonischemic Scar Distribution.

    Soto-Becerra R, Bazan V, Bautista W, et al.

    Circulation. Arrhythmia and electrophysiology 2017; (10(11)) doi:10.1161/CIRCEP.116.004950.

    PMID: 29133379
  5. 5

    Trypanosoma cruzi activates mouse cardiac fibroblasts in vitro leading to fibroblast-myofibroblast transition and increase in expression of extracellular matrix proteins.

    Coelho LL, Pereira IR, Pereira MCS, et al.

    Parasites & vectors 2018; (11(1)):72 doi:10.1186/s13071-018-2614-1.

    PMID: 29382361
  6. 6

    Changes in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas Disease.

    Garg NJ, Soman KV, Zago MP, et al.

    PLoS neglected tropical diseases 2016; (10(2)):e0004490 doi:10.1371/journal.pntd.0004490.

    PMID: 26919708
  7. 7

    Blood culture positivity rate for Trypanosoma cruzi in patients with chronic Chagas disease differs among different clinical forms.

    Nielebock MAP, de Freitas Campos Miranda L, Americano do Brasil PEA, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(6)):720-725 doi:10.1093/trstmh/traa121.

    PMID: 33150435
  8. 8

    Clinical predictors of inducible sustained ventricular tachycardia during electrophysiologic study in patients with chronic Chagas' heart disease.

    Cardinalli-Neto A, Lorga-Filho AM, Silva EF, et al.

    International journal of cardiology. Heart & vasculature 2015; (9()):85-88 doi:10.1016/j.ijcha.2015.10.001.

    PMID: 28785714
  9. 9

    Prognosis of chronic Chagas heart disease and other pending clinical challenges.

    Torres RM, Correia D, Nunes MDCP, et al.

    Memorias do Instituto Oswaldo Cruz 2022; (117()):e210172 doi:10.1590/0074-02760210172.

    PMID: 35674528
  10. 10

    Chagas disease in Virgem da Lapa, Minas Gerais, Brazil: left ventricle aneurysm and the risk of death in the 24-year interval.

    Borges-Pereira J, Coura JR, Zauza PL, et al.

    Memorias do Instituto Oswaldo Cruz 2020; (115()):e200056 doi:10.1590/0074-02760200056.

    PMID: 32556037
  11. 11

    Predictors of ischemic stroke in Chagas disease: Insights into mechanisms beyond cardiomyopathy severity.

    Lage TAR, Rocha MOC, Tupinambás JT, et al.

    International journal of cardiology 2025; (418()):132628 doi:10.1016/j.ijcard.2024.132628.

    PMID: 39395719
  12. 12

    Left Ventricular Thrombus in Hypertrophic Cardiomyopathy.

    Hamada M

    Internal medicine (Tokyo, Japan) 2019; (58(4)):465-467 doi:10.2169/internalmedicine.1646-18.

    PMID: 30333417
  13. 13

    Prevalence and risk factors of embolic cerebrovascular events associated with Chagas heart disease.

    Nunes MC, Kreuser LJ, Ribeiro AL, et al.

    Global heart 2015; (10(3)):151-7.

    PMID: 26407510
  14. 14

    Ventricular arrhythmias in chronic Chagas cardiomyopathy: Can studying myocardial sympathetic denervation provide the answers?

    Kumar V

    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2018; (25(1)):84-85 doi:10.1007/s12350-016-0587-z.

    PMID: 27406377
  15. 15

    High-Resolution ECG for Predicting Ventricular Arrhythmia in Hypertrophic Cardiomyopathy: Another Tool in the Toolbox.

    Gehi AK

    Journal of the American Heart Association 2022; (11(23)):e028095 doi:10.1161/JAHA.122.028095.

    PMID: 36444848
  16. 16

    Efficacy and safety of combined endocardial/epicardial catheter ablation for ventricular tachycardia in Chagas disease: A randomized controlled study.

    Pisani CF, Romero J, Lara S, et al.

    Heart rhythm 2020; (17(9)):1510-1518 doi:10.1016/j.hrthm.2020.02.009.

    PMID: 32087356
  17. 17

    Myocardial tissue characterization in Chagas' heart disease by cardiovascular magnetic resonance.

    Torreão JA, Ianni BM, Mady C, et al.

    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2015; (17()):97 doi:10.1186/s12968-015-0200-7.

    PMID: 26581396
  18. 18

    Chagas heart disease: A contemporary review.

    Velasco A, Morillo CA

    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2020; (27(2)):445-451 doi:10.1007/s12350-018-1361-1.

    PMID: 30022404

This page provides educational information about apical aneurysms in Chagas disease. It does not replace professional medical advice, so always consult your cardiologist regarding your specific symptoms, imaging results, and treatment plan.

Get notified when new evidence is published on American trypanosomiasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.